We are live on ! Find out more
IMA

ImageneBio Inc
IMA

42 hedge funds and large institutions have $82.8M invested in ImageneBio Inc in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

0.14% less ownership

Funds ownership: 6.17% → 6.03% (-0.14%)

9% less funds holding

Funds holding: 46 → 42 (-4)

22% less capital invested

Capital invested by funds: $106M → $82.8M (-$22.9M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
42
Holders Change
-4
Holders Change %
-8.7%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
5
Increased
18
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.16M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$1.34M
4
BlackRock
BlackRock
New York
+$1.03M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$647K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.01M
2
FCM
Farallon Capital Management
California
-$1.28M
3
Millennium Management
Millennium Management
New York
-$1.04M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$181K
5
Morgan Stanley
Morgan Stanley
New York
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$68K -$24.7K -428 -21%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$45K +$14.9K +258 +30%
Goldman Sachs
28
Goldman Sachs
New York
$44K -$53.7K -928 -47%
Charles Schwab
29
Charles Schwab
California
$43K +$58.2K +1,006 New
TRCT
30
Tower Research Capital (TRC)
New York
$13K +$3.24K +56 +21%
BWM
31
Baystate Wealth Management
Massachusetts
$11K – – –
O
32
OrbiMed
New York
$10.4K – – –
Zurich Cantonal Bank
33
Zurich Cantonal Bank
Switzerland
$9K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$9K +$5.15K +89 +77%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$3.46K +$4.68K +81 New
Citigroup
36
Citigroup
New York
$2K -$1.21K -21 -27%
Bank of America
37
Bank of America
North Carolina
$2K +$1.45K +25 +96%
MA
38
MUFG Americas
New York
$2K +$2.2K +38 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K +$173 +3 +19%
Wells Fargo
40
Wells Fargo
California
$1K +$463 +8 +57%
CUAMC
41
China Universal Asset Management Company
China
$1K +$1.62K +28 New
FCM
42
Farallon Capital Management
California
– -$1.28M -24,167 Closed
Millennium Management
43
Millennium Management
New York
– -$1.04M -19,652 Closed
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
– -$181K -3,410 Closed
CSS
45
Cubist Systematic Strategies
Connecticut
– -$92K -1,727 Closed
VF
46
Virtu Financial
New York
– -$69K -1,295 Closed
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
– -$1K -17 Closed
1
2

IMA Hedge Fund Activity: Q3 2022 in Review

42 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2022, worth a combined $82.8M — down 22% from $106M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IMA and 5 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 18 added.

The largest buyer was Point72 Asset Management, adding an estimated $3.16M. The largest seller was Fidelity Investments, cutting an estimated $9.01M.

  • 42 institutional investors held ImageneBio Inc (IMA) as of Q3 2022, down from 46 in Q2 2022.
  • Funds reported $82.8M of ImageneBio Inc stock for Q3 2022, down 22% quarter-over-quarter.
  • 5 funds opened new ImageneBio Inc positions in Q3 2022 and 8 closed out, a net change of -3 holders.
  • The largest ImageneBio Inc buyer in Q3 2022 was Point72 Asset Management, an estimated $3.16M added.
  • The largest ImageneBio Inc seller in Q3 2022 was Fidelity Investments, an estimated $9.01M sold.

Based on aggregated 13F filings for Q3 2022.